Thank You!


You have made a smart decision! Please check your email to ensure you don’t miss any of our exciting offers and information.
 
Archives
Wednesday, 28 September 2005 00:00

Clinical Trials Update: Sept. 28, 2005

  • <div class="fb-like" data-send="false" data-layout="button_count" data-width="200" data-show-faces="true" data-font="verdana"
    Tweet

(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Pregnancy Complications

Antiphospholipid antibody syndrome (APS) is a medical problem that is associated with health risks for the pregnant mother and her baby. Initial selection criteria for the study include women between 18 and 44 years of age, diagnosis of antiphospholipid antibody syndrome and able to safely undergo treatment with heparin. Research site located in Chicago, Ill.

More Information

Please see http://www.centerwatch.com/patient/studies/cat650.html.

—–

Insomnia

Clinilabs, a healthcare service provider and research facility, is looking for people 18-64 years of age who suffer from both anxiety and insomnia to participate in a clinical research study of an investigational medication. This study will consist of eight visits to a Manhattan office over a period of four months. Research site located in New York, NY.

More Information

Please seo tips see http://www.centerwatch.com/patient/studies/cat189.html.

—–

Thyroid Cancer

The purpose of this study is to assess the efficacy and safety of irofulven/capecitabine combination therapy in patients with anaplastic, medullary, or locally advanced/metastatic differentiated thyroid cancer. To be included in this study, you must meet the following criteria: 18 years of age or older and cancer of the thyroid confirmed by a biopsy sample. Research site located in Pittsburgh, Penn.

More Information

Please companies see http://www.centerwatch.com/patient/studies/cat641.html.

—–

Copyright seo services 2005 CenterWatch. All rights reserved.